$33.90
0.50% today
Nasdaq, Feb 28, 04:23 pm CET
ISIN
US74265M2052
Symbol
PDEX

Pro-Dex, Inc. Stock price

$33.73
-7.54 18.27% 1M
+12.10 55.94% 6M
-13.02 27.85% YTD
+17.23 104.42% 1Y
+15.17 81.73% 3Y
+15.69 86.92% 5Y
+31.65 1,521.63% 10Y
Nasdaq, Closing price Thu, Feb 27 2025
+0.51 1.54%
ISIN
US74265M2052
Symbol
PDEX
Sector

Key metrics

Market capitalization $109.99m
Enterprise Value $123.05m
P/E (TTM) P/E ratio 16.84
EV/FCF (TTM) EV/FCF 75.03
EV/Sales (TTM) EV/Sales 2.02
P/S ratio (TTM) P/S ratio 1.80
P/B ratio (TTM) P/B ratio 3.46
Revenue growth (TTM) Revenue growth 26.45%
Revenue (TTM) Revenue $61.00m
EBIT (operating result TTM) EBIT $10.27m
Free Cash Flow (TTM) Free Cash Flow $1.64m
Cash position $4.74m
EPS (TTM) EPS $2.00
P/S forward 1.62
EV/Sales forward 1.81
Short interest 5.30%
Show more

Is Pro-Dex, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,809 stocks worldwide.

Pro-Dex, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

1 Analyst has issued a forecast Pro-Dex, Inc.:

1x Buy
100%

Analyst Opinions

1 Analyst has issued a forecast Pro-Dex, Inc.:

Buy
100%

Financial data from Pro-Dex, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
61 61
26% 26%
100%
- Direct Costs 42 42
23% 23%
70%
19 19
34% 34%
30%
- Selling and Administrative Expenses 3.66 3.66
6% 6%
6%
- Research and Development Expense 3.38 3.38
13% 13%
6%
11 11
57% 57%
19%
- Depreciation and Amortization 1.21 1.21
16% 16%
2%
EBIT (Operating Income) EBIT 10 10
63% 63%
17%
Net Profit 6.75 6.75
35% 35%
11%

In millions USD.

Don't miss a Thing! We will send you all news about Pro-Dex, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Pro-Dex, Inc. Stock News

Positive
Seeking Alpha
29 days ago
In 4Q24, we crossed $10M in AUM, emphasizing patient growth and strategic portfolio management, with a focus on long-term investments and five-year doubles. Key drivers include CCRD, PDEX, and RSSS, with CoreCard benefiting from a new contract with Goldman, and Pro-Dex showing strong business performance. Matrix Service is expected to convert backlog to profit in the next 18-24 months, while ne...
Neutral
Accesswire
29 days ago
IRVINE, CA / ACCESS Newswire / January 30, 2025 / PRO-DEX, INC. (NasdaqCM:PDEX) today announced financial results for its fiscal 2025 second quarter ended December 31, 2024.
Neutral
Accesswire
4 months ago
IRVINE, CA / ACCESSWIRE / October 31, 2024 / PRO-DEX, INC. (NASDAQ:PDEX) today announced financial results for its fiscal 2025 first quarter ended September 30, 2024.
More Pro-Dex, Inc. News

Company Profile

Pro-Dex, Inc. engages in the design, development, and manufacture of rotary drive surgical and dental instruments used primarily in the orthopedic, spine, maxocranial facial and dental markets. It specializes in medical device and services, industrial and scientific, dental and component, repairs, and other. Its products include finished medical devices, micro air-motors, dental products, plastic injection molding, and torque wrenches. The company was founded on January 26, 1994 and is headquartered in Irvine, CA.

Head office United States
CEO Richard Kirk
Employees 148
Founded 1994
Website www.pro-dex.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today